Cancer patients have largely been excluded from COVID-19 vaccine trials, and the American Society of Clinical Oncology is asking drug manufacturers to change that in an effort to deduce whether the safety and effectiveness extends to these often-immunocompromised patients.
from Section Page News - Modern Healthcare https://ift.tt/3gYhWsb
No comments:
Post a Comment